Skip to content

Prospective observational study on Improvement of prognosis of Pancreatic Cancer: Early Detection Project of Pancreatic Cancer in Tsu

Prospective observational study on Improvement of prognosis of Pancreatic Cancer: Early Detection Project of Pancreatic Cancer in Tsu - PIPED-Tsu

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041624
Enrollment
150
Registered
2020-08-31
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Sponsors

Mie University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults aged 20 years or older having 2 or more points on a scoring metric for prespecified pancreatic cancer risk factors will be eligible for referral. Prespecified risk factors and associated point scores are as follows: 1. symptoms (abdominal pain, jaundice, back pain, or weight loss): 1 point 2. newly diagnosed diabetes mellitus (type 2) or worsening of diabetes: 1 point 3. family history of PC (parent, child, or siblings, including other types of pancreatic neoplasms): 1 point 4. abnormal serum amylase level (high or low): 1 point 5. elevated serum CA19-9 level: 1 point 6. pancreatic duct dilation (>3 mm) or pancreatic cyst detected by echography test: 2 points.

Exclusion criteria

Exclusion criteria: 1) Patients who cannot understand the necessity of detailed examination and follow-up due to cognitive decline etc. 2) Patients who the investigator/co-investigator determined to be inappropriate for inclusion in the study

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the rate of patients diagnosed with pancreatic cancer, calculated with a 95% confidence interval. The diagnosis rate is the number of patients diagnosed/total number of study participants.

Countries

Japan

Contacts

Public ContactReiko Yamada

Mie University Hospital Gastroenterology and Hepatology

reiko-t@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026